Condition

Gene Mutation (4)

Clinical Disease and/or Syndrome (1)

Epilepsy Idiopathic (1)

Germline Mutation Carrier (1)

Lynch Syndrome (1)

Pancreas Cancer (1)

Peutz-Jeghers Syndrome (PJS) (1)

Overall Status

Recruiting (2)

Enrolling by invitation (1)

Unknown status (1)

Phase

early phase 1 (1)

phase 3 (1)

Sponsor

Beijing Tiantan Hospital (1)

Fudan University (1)

Johns Hopkins University (1)

The First Hospital of Jilin University (1)

Intervention

kapa hyper prep kit + agilent sureselectqxt (1)

mri (1)

non (1)

rag-17 (1)

secretin (1)

tumor marker gene test with ca19-9 (1)

Study Documents

Intervention Type

diagnostic test (2)

drug (2)

other (2)

Funder Type

Other (4)

Study Type

Interventional (2)

Observational (2)

gene mutation

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Gene Mutation Trial in Beijing (RAG-17)

Enrolling by invitation

Gene Mutation

RAG-17

Beijing, China

Beijing Tiantan Hospital

Jun 11, 2023

Pancreas Cancer, Peutz-Jeghers Syndrome (PJS), Gene Mutation Trial in United States (drug, diagnostic test, other)

Recruiting

Pancreas Cancer
+4 more

Secretin
+2 more

New Haven, Connecticut
+7 more

Dec 12, 2022

Different Genetic Mutations on Prognosis in sMPLC Adenocarcinoma

Recruiting

Gene Mutation

KAPA Hyper Prep Kit + Agilent SureSelectQXT

Changchun, Jilin, China

The first hospital of Jilin University

Oct 12, 2021

Omics-based Precision Medicine of Epilepsy

Unknown status

Epilepsy Idiopathic
+2 more

Shanghai, Shanghai, China

Children's Hospital of Fudan University

Nov 29, 2017